PATENT CLAIM ANALYSIS

Application Number: 16178198
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["424", "400000"]

Abstract:
In one aspect, the present invention relates to a new method of treating or osteoarthritis in a mammal in need thereof. In certain embodiments, the method comprises contacting at least one biomimetic proteoglycan with the affected joint of the mammal. The biomimetic proteoglycan comprises a core structure and at least one bristle. The biomimetic proteoglycan resists endogenous enzymatic degradation and integrates with the existing tissue matrix.

Claim (Index 4):
The method of  claim 1 , wherein the biomimetic proteoglycan comprises a core structure and at least one glycosaminoglycan (GAG), wherein the core structure and the GAG are covalently linked, and wherein the GAG is at least one selected from the group consisting of hyaluronic acid, chondroitin, chondroitin sulfate, heparin, heparin sulfate, dermatan sulfate, laminin, keratin sulfate, chitin, chitosan, acetyl-glucosamine, and oligosaccharides.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 98.0
- Lexical Diversity: 1.6
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14004944', '10896546', '13173658', '14119341', '14914452']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.766852991127628
- 35 USC 102 Novelty (BERT): 0.5166187823812198
- Combined Prediction Score: 0.7418295702529871
- Mean Citation Score: 279.74082000000004
- Max Citation Score: 312.3952
- Similarity Product: 221.9496027967453

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test